T cell immunity and cardiovascular metabolic disorders: Does metabolism fuel inflammation?

Frontiers in Immunology

Volumn 3, Issue JUN, 2012, Pages

  Mauro, Claudio ^a   Marelli Berg, Federica M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874077529     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00173     Document Type: Article

References (43)

1. Adelman, S. J. (2010). Sirolimus and its analogs and its effects on vascular diseases. Curr. Pharm. Des. 16, 4002-4011.
2. Ait-Oufella, H., Salomon, B. L., Potteaux, S., Robertson, A. K., Gourdy, P., Zoll, J., Merval, R., Esposito, B., Cohen, J. L., Fisson, S., Flavell, R. A., Hansson, G. K., Klatzmann, D., Tedgui, A., and Mallat, Z. (2006). Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12, 178-180.
3. Baker, R. G., Hayden, M. S., and Ghosh, S. (2011). NF-kappaB, inflammation, and metabolic disease. Cell Metab. 13, 11-22.
4. Burman, A., Haworth, O., Hardie, D. L., Amft, E. N., Siewert, C., Jackson, D. G., Salmon, M., and Buckley, C. D. (2005). A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis. J. Immunol. 174, 1693-1700.
5. Cottin, S. C., Sanders, T. A., and Hall, W. L. (2011). The differential effects of EPA and DHA on cardiovascular risk factors. Proc. Nutr. Soc. 70, 215-231.
6. de Boer, O. J., van der Meer, J. J., Teeling, P., van der Loos, C. M., and van der Wal, A. C. (2007). Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS ONE 2, e779. doi: 10.1371/journal.pone.0000779
7. Donath, M. Y., and Shoelson, S. E. (2011). Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98-107.
8. Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S., and Mathis, D. (2009). Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930-939.
9. Finlay, D., and Cantrell, D. A. (2011). Metabolism, migration and memory in cytotoxic T cells. Nat. Rev. Immunol. 11, 109-117.
10. Frauwirth, K. A., and Thompson, C. B. (2004). Regulation of T lymphocyte metabolism. J. Immunol. 172, 4661-4665.
11. Full, L. E., and Monaco, C. (2011). Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis. Cardiovasc. Ther. 29, 231-242.
12. Gareus, R., Kotsaki, E., Xanthoulea, S., van der Made, I., Gijbels, M. J., Kardakaris, R., Polykratis, A., Kollias, G., de Winther, M. P., and Pasparakis, M. (2008). Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab. 8, 372-383.
13. Gerriets, V. A., and Rathmell, J. C. (2012). Metabolic pathways in T cell fate and function. Trends Immunol. 33, 168-173.
14. Greenberg, J. D., Furer, V., and Farkouh, M. E. (2011). Cardiovascular safety of biologic therapies for the treatment of RA. Nat. Rev. Rheumatol. 15, 13-21.
15. Gupta, S., Pablo, A. M., Jiang, X., Wang, N., Tall, A. R., and Schindler, C. (1997). IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99, 2752-2761.
16. Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., and Harrison, D. G. (2007). Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 204, 2449-2460.
17. Hansson, G. K., and Hermansson, A. (2011). The immune system in atherosclerosis. Nat. Immunol. 12, 204-212.
18. Harrison, D. G., Vinh, A., Lob, H., and Madhur, M. S. (2010). Role of the adaptive immune system in hypertension. Curr. Opin. Pharmacol. 10, 203-207.
19. Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. Nature 444, 860-867.
20. Jacobsson, L. T., Turesson, C., Gulfe, A., Kapetanovic, M. C., Petersson, I. F., Saxne, T., and Geborek, P. (2005). Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J. Rheumatol. 32, 1213-1218.
21. Jarmin, S. J., David, R., Ma, L., Chai, J. G., Dewchand, H., Takesono, A., Ridley, A. J., Okkenhaug, K., and Marelli-Berg, F. M. (2008). T cell receptor-induced phosphoinositide-3-kinase p110 delta activity is required for T cell localization to antigenic tissue in mice. J. Clin. Invest. 118, 1154-1164.
22. Jones, R. G., and Thompson, C. B. (2007). Revving the engine: signal transduction fuels T cell activation. Immunity 27, 173-178.
23. Lahoute, C., Herbin, O., Mallat, Z., and Tedgui, A. (2011). Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets. Nat. Rev. Cardiol. 8, 348-358.
24. Mahmoud, F., Omu, A., Abul, H., El-Rayes, S., and Haines, D. (2003). Lymphocyte subpopulations in pregnancy complicated by hypertension. J. Obstet. Gynaecol. 23, 20-26.
25. Marelli-Berg, F. M., Fu, H., and Mauro, C. (2012). Molecular mechanisms of metabolic reprogramming in proliferating cells: implications for T cell-mediated immunity. Immunology. doi: 10.1111/j.13652567.2012.03583.x. [Epub ahead of print].
26. Matarese, G., Procaccini, C., De Rosa, V., Horvath, T. L., and La Cava, A. (2010). Regulatory T cells in obesity: the leptin connection. Trends Mol. Med. 16, 247-256.
27. Mathis, D., and Shoelson, S. E. (2011). Immunometabolism: an emerging frontier. Nat. Rev. Immunol. 11, 81.
28. Mauro, C., Fu, H., and Marelli-Berg, F. M. (2012). T cell trafficking and metabolism: novel mechanisms and targets for immunomodulation. Curr. Opin. Pharmacol. doi: 10.1016/j.coph.2012.02.018. [Epub ahead of print].
29. Mauro, C., Leow, S. C., Anso, E., Rocha, S., Thotakura, A. K., Tornatore, L., Moretti, M., De Smaele, E., Beg, A. A., Tergaonkar, V., Chandel, N. S., and Franzos, G. (2011). NF-kappaB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration. Nat. Cell Biol. 13, 1272-1279.
30. Mirenda, V., Jarmin, S. J., David, R., Dyson, J., Scott, D., Gu, Y., Lechler, R. I., Okkenhaug, K., and Marelli-Berg, F. M. (2007). Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28. Blood 109, 2968-2977.
31. Peter, C., Waldmann, H., and Cobbold, S. P. (2010). mTOR signalling and metabolic regulation of T cell differentiation. Curr. Opin. Immunol. 22, 655-661.
32. Powell, J. D., and Delgoffe, G. M. (2010). The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity 33, 301-311.
33. Purkayastha, S., Zhang, G., and Cai, D. (2011). Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-beta and NF-kappaB. Nat. Med. 17, 883-887.
34. Ranjbaran, H., Sokol, S. I., Gallo, A., Eid, R. E., Iakimov, A. O., D'Alessio, A., Kapoor, J. R., Akhtar, S., Howes, C. J., Aslan, M., Pfau, S., Pober, J. S., and Tellides, G. (2007). An inflammatory pathway of IFN-gamma production in coronary atherosclerosis. J. Immunol. 178, 592-604.
35. Rathmell, J. C., Vander Heiden, M. G., Harris, M. H., Frauwirth, K. A., and Thompson, C. B. (2000). In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol. Cell 6, 683-692.
36. Rocha, V. Z., and Libby, P. (2009). Obesity, inflammation, and atherosclerosis. Nat. Rev. Cardiol. 6, 399-409.
37. Schiffrin, E. L. (2010). T lymphocytes: a role in hypertension? Curr. Opin. Nephrol. Hypertens. 19, 181-186.
38. Seaberg, E. C., Munoz, A., Lu, M., Detels, R., Margolick, J. B., Riddler, S. A., Williams, C. M., and Phair, J. P. (2005). Association between highly active antiretro-viral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 19, 953-960.
39. Shao, J., Nangaku, M., Miyata, T., Inagi, R., Yamada, K., Kurokawa, K., and Fujita, T. (2003). Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 42, 31-38.
40. Sinclair, L. V., Finlay, D., Feijoo, C., Cornish, G. H., Gray, A., Ager, A., Okkenhaug, K., Hagenbeek, T. J., Spits, H., and Cantrell, D. A. (2008). Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat. Immunol. 9, 513-521.
41. Sucher, R., Fischler, K., Oberhuber, R., Kronberger, I., Margreiter, C., Ollinger, R., Schneeberger, S., Fuchs, D., Werner, E. R., Watschinger, K., Zelger, B., Tellides, G., Pilat, N., Pratschke, J., Margreiter, R., Wekerle, T., and Brandacher, G. (2012). IDO and regulatory T cell support are critical for cytotoxic T lymphocyteassociated Ag-4 Ig-mediated long-term solid organ allograft survival. J. Immunol. 188, 37-46.
42. Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z. W., Karin, M., and Shoelson, S. E. (2001). Reversal of obesityand diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293, 1673-1677.
43. Zheng, Y., Delgoffe, G. M., Meyer, C. F., Chan, W., and Powell, J. D. (2009). Anergic T cells are metabolically anergic. J. Immunol. 183, 6095-6101.